BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

LD-2 disclosure · 2nd Quarter - Termination

SEQIRUS, INC.

via BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ

2nd Quarter (Apr 1 - June 30) · 2017Posted Jun 7, 2017Filing document ↗LDA record ↗

Income$5Kfee reported

Client

Name: SEQIRUS, INC.
Description: Manufacturer of pandemic influenza vaccines
Location: District of Columbia · United States of America

Registrant

Firm: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
Description: Law firm
Location: Washington, District of Columbia, United States of America

Lobbying activities

1 issue

Budget/Appropriations
Labor, Health and Human Services and Education Appropriations bills.
Lobbyistsms SARA LOVE RAWLINGS
TargetedSENATE · HOUSE OF REPRESENTATIVES

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.

SEQIRUS, INC. — Lobbying — Receipts Report